# REXULTI
> **NDA205422** · New Drug Application · Sponsor: OTSUKA · Approved 2015-07-10
## Drug
- **FDA Application Number:** NDA205422
- **Application type:** New Drug Application
- **Brand name:** REXULTI
- **Generic name:** BREXPIPRAZOLE
- **Active ingredients:** BREXPIPRAZOLE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** OTSUKA
- **Manufacturer:** Otsuka America Pharmaceutical, Inc.
- **First approval:** 2015-07-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205422)
---
*MORVS · CC0 1.0*